Doxercalciferol
Doxercalciferol, Hectorol (doxercalciferol) is a small molecule pharmaceutical. Doxercalciferol was first approved as Doxercalciferol on 1999-06-09. It is used to treat hyperparathyroidism in the USA. It is known to target vitamin D3 receptor and vitamin D 25-hydroxylase.
| Trade Name | Doxercalciferol, Hectorol |
|---|---|
| Common Name | Doxercalciferol |
| Indication | hyperparathyroidism |
| Drug Class | Vitamin D analogues |
